Develops drugs for cancers.
Jun 2026Revenue $79.6M/yrExpenses $179M/yr
No trendCash runway ≈ 2.1 years from Jun 2026
Figures by year
When will ADC Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $79.6M and expenses $179M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $81.4M | $203M | −$121M |
| Dec 2024 | $70.8M | $201M | −$131M |
| Dec 2023 | $69.6M | $236M | −$166M |
| Dec 2022 | $210M | $333M | −$123M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.